Keywords: shire, alzheimer, drug, shows, promise, pharmaceuticals, presented
Shire's Alzheimer's Drug Shows Promise
Article | 05 August 1996
Shire Pharmaceuticals has presented promising results of its Phase II study with galanthamine, its treatment for Alzheimer's disease. Data were ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
